Erratum: FDPP-HA as a theranostic agent for cancer-targeted fluorescence imaging and photodynamic therapy (RSC Advances (2017) 7 (37369–37373) DOI: 10.1039/C7RA06551E)

Pingping Liang; Jinjun Shao; Qianyun Tang; Weili Si; Qiang Wang; Qi Zhang; Xiaochen Dong

doi:10.1039/d3ra90050a

Erratum: FDPP-HA as a theranostic agent for cancer-targeted fluorescence imaging and photodynamic therapy (RSC Advances (2017) 7 (37369–37373) DOI: 10.1039/C7RA06551E)

Pingping Liang, Jinjun Shao, Qianyun Tang, Weili Si, Qiang Wang, Qi Zhang, Xiaochen Dong

Nanjing Tech University

Research output: Contribution to journal › Comment/debate

Abstract

In the original article in Fig. 6, incorrect H&E staining images were inserted for the control group (liver) and illumination group (spleen and kidney). The corrected versions are included below. The authors apologise for any inconvenience caused. The results and conclusions of this paper are not affected by this correction. (Figure Presented). The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.

Original language	English
Pages (from-to)	17621
Number of pages	1
Journal	RSC Advances
Volume	13
Issue number	26
DOIs	https://doi.org/10.1039/d3ra90050a
State	Published - 12 Jun 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1039/d3ra90050a

Cite this

@article{64ea4df6a6d24ef0bdca32d2dc03a43d,

title = "Erratum: FDPP-HA as a theranostic agent for cancer-targeted fluorescence imaging and photodynamic therapy (RSC Advances (2017) 7 (37369–37373) DOI: 10.1039/C7RA06551E)",

abstract = "In the original article in Fig. 6, incorrect H&E staining images were inserted for the control group (liver) and illumination group (spleen and kidney). The corrected versions are included below. The authors apologise for any inconvenience caused. The results and conclusions of this paper are not affected by this correction. (Figure Presented). The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.",

author = "Pingping Liang and Jinjun Shao and Qianyun Tang and Weili Si and Qiang Wang and Qi Zhang and Xiaochen Dong",

note = "Publisher Copyright: {\textcopyright} 2023 The Royal Society of Chemistry.",

year = "2023",

month = jun,

day = "12",

doi = "10.1039/d3ra90050a",

language = "英语",

volume = "13",

pages = "17621",

journal = "RSC Advances",

issn = "2046-2069",

publisher = "Royal Society of Chemistry",

number = "26",

}

TY - JOUR

T1 - Erratum

T2 - FDPP-HA as a theranostic agent for cancer-targeted fluorescence imaging and photodynamic therapy (RSC Advances (2017) 7 (37369–37373) DOI: 10.1039/C7RA06551E)

AU - Liang, Pingping

AU - Shao, Jinjun

AU - Tang, Qianyun

AU - Si, Weili

AU - Wang, Qiang

AU - Zhang, Qi

AU - Dong, Xiaochen

PY - 2023/6/12

Y1 - 2023/6/12

N2 - In the original article in Fig. 6, incorrect H&E staining images were inserted for the control group (liver) and illumination group (spleen and kidney). The corrected versions are included below. The authors apologise for any inconvenience caused. The results and conclusions of this paper are not affected by this correction. (Figure Presented). The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.

AB - In the original article in Fig. 6, incorrect H&E staining images were inserted for the control group (liver) and illumination group (spleen and kidney). The corrected versions are included below. The authors apologise for any inconvenience caused. The results and conclusions of this paper are not affected by this correction. (Figure Presented). The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.

UR - http://www.scopus.com/inward/record.url?scp=85162742589&partnerID=8YFLogxK

U2 - 10.1039/d3ra90050a

DO - 10.1039/d3ra90050a

M3 - 评论/辩论

AN - SCOPUS:85162742589

SN - 2046-2069

VL - 13

SP - 17621

JO - RSC Advances

JF - RSC Advances

IS - 26

ER -

Erratum: FDPP-HA as a theranostic agent for cancer-targeted fluorescence imaging and photodynamic therapy (RSC Advances (2017) 7 (37369–37373) DOI: 10.1039/C7RA06551E)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this